申请人:Janssen Pharmaceutica NV
公开号:US20170233401A1
公开(公告)日:2017-08-17
Disclosed are compounds, compositions and methods for treating of disorders that are affected by the antagonism of one or more androgen receptor types. Such compounds are represented by Formula (I) as follows:
wherein R
1
and G are defined herein.